Literature DB >> 27376814

Immunogenicity and prediction of epitopic region of antigen Ag I/II and glucosyltransferase from Streptococcus mutans.

Xi-Xi Cao1, Jian Fan2, Jiang Chen2, Yu-Hong Li3, Ming-Wen Fan4.   

Abstract

The levels of Streptococcus (S.) mutans infections in saliva were evaluated and a comparison for specific antibody levels among children with different levels of S. mutans infection was made. The promising epitopic regions of antigen AgI/II (PAc) and glucosyltransferase (GTF) for potential vaccine targets related to S. mutans adherence were screened. A total of 94 children aged 3-4 years were randomly selected, including 53 caries-negative and 41 caries-positive children. The values of S. mutans and those of salivary total secretory immunoglobulin A (sIgA), anti-PAc and anti-Glucan binding domain (anti-GLU) were compared to determine the correlation among them. It was found the level of s-IgA against specific antigens did not increase with increasing severity of S. mutans infection, and the complete amino acid sequence of PAc and GTFB was analyzed using the DNAStar Protean system for developing specific anti-caries vaccines related to S. mutans adherence. A significantly positive correlation between the amount of S. mutans and children decayed, missing, and filled teeth index was observed. No significant difference was detected in specific sIgA against PAc or GLU between any two groups. No significant correlation was found between such specific sIgA and caries index. A total of 16 peptides from PAc as well as 13 peptides from GTFB were chosen for further investigation. S. mutans colonization contributed to early children caries as an important etiological factor. The level of sIgA against specific antigens did not increase with increasing severity of S. mutans infection in children. The epitopes of PAc and GTF have been screened to develop the peptide-based or protein-based anti-caries vaccines.

Entities:  

Keywords:  Streptococcus mutans; anti-caries vaccine; bioinformatics; secretory immunoglobulin A

Mesh:

Substances:

Year:  2016        PMID: 27376814     DOI: 10.1007/s11596-016-1602-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  18 in total

1.  Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.

Authors:  Chandan Thomas; Amit Rawat; Louisa Hope-Weeks; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2011-01-11       Impact factor: 4.939

2.  Genetic profiling of the oral microbiota associated with severe early-childhood caries.

Authors:  Y Li; Y Ge; D Saxena; P W Caufield
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

3.  Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.

Authors:  Shizhen Zhang; Nicole M Green; Izabela Sitkiewicz; Rance B Lefebvre; James M Musser
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Nanoparticle vaccines.

Authors:  Liang Zhao; Arjun Seth; Nani Wibowo; Chun-Xia Zhao; Neena Mitter; Chengzhong Yu; Anton P J Middelberg
Journal:  Vaccine       Date:  2013-12-02       Impact factor: 3.641

Review 5.  Genome-based approaches to vaccine development.

Authors:  Marirosa Mora; John L Telford
Journal:  J Mol Med (Berl)       Date:  2010-02       Impact factor: 4.599

6.  Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering.

Authors:  Tewodros Mamo; Gregory A Poland
Journal:  Vaccine       Date:  2012-10-19       Impact factor: 3.641

Review 7.  Biology, immunology, and cariogenicity of Streptococcus mutans.

Authors:  S Hamada; H D Slade
Journal:  Microbiol Rev       Date:  1980-06

8.  Elongated fibrillar structure of a streptococcal adhesin assembled by the high-affinity association of alpha- and PPII-helices.

Authors:  Matthew R Larson; Kanagalaghatta R Rajashankar; Manisha H Patel; Rebekah A Robinette; Paula J Crowley; Suzanne Michalek; L Jeannine Brady; Champion Deivanayagam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

9.  Protective efficacy of a targeted anti-caries DNA plasmid against cariogenic bacteria infections.

Authors:  Q A Xu; F Yu; M W Fan; Z Bian; Z Chen; B Peng; R Jia; J H Guo
Journal:  Vaccine       Date:  2006-10-24       Impact factor: 3.641

10.  Prion (PrPSc)-specific epitope defined by a monoclonal antibody.

Authors:  C Korth; B Stierli; P Streit; M Moser; O Schaller; R Fischer; W Schulz-Schaeffer; H Kretzschmar; A Raeber; U Braun; F Ehrensperger; S Hornemann; R Glockshuber; R Riek; M Billeter; K Wüthrich; B Oesch
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

View more
  2 in total

1.  Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents.

Authors:  Xi-Xi Cao; Yu-Hong Li; Qian-Lin Ye; Xuan Hu; Tian-Feng Wang; Ming-Wen Fan
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  Antibodies generated against dextransucrase exhibit potential anticariostatic properties in Streptococcus mutans.

Authors:  Shabeer Ahmad Rather; Sukesh Chander Sharma; Akhtar Mahmood
Journal:  Appl Microbiol Biotechnol       Date:  2020-01-03       Impact factor: 4.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.